Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin Dose Escalation in TB
NCT01329250Phase 4Terminated
- Sponsor
- University Medical Center Groningen
- Start
- May 2011
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of moxifloxacin in Tuberculosis (TB), sponsored by University Medical Center Groningen. Started May 2011; status: terminated.
02
Drugs
moxifloxacin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01329250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01329250.